← Back to all earnings calls

TScan Therapeutics, Inc. Q2 FY2022 Earnings Call

TScan Therapeutics, Inc. (TCRX)

Earnings Call FY2022 Q2 Call date: 2022-08-10 Concluded

Share

Quarter scorecard

Revenue

$4.06M

+42.4% YoY

Diluted EPS

$-0.63

Net income

$

Documents & deck